Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Sale of 520 KRYS shares, $184.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 520 | $184.4K |
| Jun 5, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 320 | $96.2K |
| Mar 6, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 483 | $124.3K |
| Mar 3, 2026 | Krystal Biotech, Inc. (KRYS) | Exercise/Conversion | 8,750 | n/a |
| Dec 5, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 956 | $204.9K |
| Jul 16, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 13,400 | $2.01M |
| Jul 11, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 200 | $30.0K |
| Mar 13, 2025 | Krystal Biotech, Inc. (KRYS) | Sale | 1,100 | $193.4K |
| Feb 28, 2025 | Krystal Biotech, Inc. (KRYS) | Tax Withholding | 4,721 | $832.7K |
| Dec 13, 2024 | Krystal Biotech, Inc. (KRYS) | Sale | 6,302 | $1.03M |